title: A case of Sweet's syndrome due to 5-Azacytidine and vorinostat in a patient with NK/T cell lymphoma.
authors.affiliation: Department of Hematology-Oncology, National University Health System, 1E Kent Ridge Road, Singapore.
authors.forename: Angela
authors.initials: A
authors.lastname: Pang
authors.forename: Kong Bing
authors.initials: KB
authors.lastname: Tan
authors.forename: Derrick
authors.initials: D
authors.lastname: Aw
authors.forename: Wen-Son
authors.initials: WS
authors.lastname: Hsieh
authors.forename: Boon Cher
authors.initials: BC
authors.lastname: Goh
authors.forename: Soo Chin
authors.initials: SC
authors.lastname: Lee
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols; D001374:Azacitidine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D054391:Lymphoma, Extranodal NK-T-Cell / Q000188:drug therapy / Q000473:pathology; D016463:Sweet Syndrome / Q000139:chemically induced* / Q000473:pathology; D000077337:Vorinostat
chemical_list: D000970:Antineoplastic Agents; D006877:Hydroxamic Acids; D000077337:Vorinostat; D001374:Azacitidine